Regulator defends its decision to delay use of hybrid embryosBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39119.525556.DB (Published 08 February 2007) Cite this as: BMJ 2007;334:281
- Adrian O'Dowd
The fertility regulator has defended its decision to halt applications for human hybrid research in the United Kingdom during a parliamentary inquiry.
The Human Fertilisation and Embryology Authority (HFEA), independent regulator of in vitro fertilisation treatment and embryo research in the UK, said that research involving hybrids of human and animal cells was “very new and very controversial.”
Representatives from the authority were giving evidence to the cross party science and technology committee of MPs as part of its inquiry into government proposals to regulate the creation of animal-human hybrid embryos for research.
The government has published a white …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial